Inaktiver Wert

Andere Sprachen Oramed Pharmaceuticals, Inc. OTC Bulletin Board

Aktien

US68403P1049

Schlusskurs OTC Bulletin Board Andere Börsenplätze
- ^USD	-

12.06.	Scilex Holding unterzeichnet Verpflichtungserklärung für $100 Millionen-Finanzierung; Aktien steigen vorbörslich an	MT
10.06.	Oramed Pharmaceuticals Inc. ernennt Herrn Avraham Gabay zum Schatzmeister und Sekretär mit Wirkung zum 18. Juni 2024	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Scilex Holding Signs Commitment Letter for $100 Million Financing; Shares Advance Premarket	12.06.
Oramed Pharmaceuticals Inc. Appoints Mr. Avraham Gabay as Chief Financial Officer, Effective as of June 18, 2024	10.06.
Oramed Pharmaceuticals Inc. Appoints Mr. Avraham Gabay as Treasurer and Secretary, Effective as of June 18, 2024	10.06.
Compugen Names David Silberman CFO	15.05.
Oramed Pharmaceuticals Inc. Announces Resignation of David Silberman as Chief Financial Officer, Effective July 12, 2024	13.05.
Oramed Pharmaceuticals Inc. Announces Resignation of David Silberman as Treasurer and Secretary, Effective July 12, 2024	13.05.
Oramed Pharmaceuticals : Management Change/Compensation - Form 8-K	13.05.
Oramed: Q1 Earnings Snapshot	10.05.
Oramed Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09.05.
Oramed Pharmaceuticals : Update on the receipt of payments for the Scilex transaction	06.05.
Oramed Pharmaceuticals : 13D-Nadav Kidron	26.03.
Oramed Pharmaceuticals : Update on the receipt of payments for the Scilex transaction	19.03.
Oramed Pharmaceuticals Inc. Appoints Yehuda Reznick as Director, Effective as of April 1, 2024	19.03.
Oramed Pharmaceuticals : Other Report or Announcement	18.03.
Oramed Pharmaceuticals : Other Report or Announcement	18.03.
Oramed Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	06.03.
Oramed Pharmaceuticals Inc. Announces Resignation of Yadin Rozov from the Board of Directors	19.01.
Oramed Pharmaceuticals : Other Report or Announcement	02.01.
Oramed Pharmaceuticals : Other Report or Announcement	24.12.
Oramed Pharmaceuticals Inc. Appoints Daniel Aghion as Director, Effective January 1, 2024	19.12.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Oramed Pharmaceuticals, Inc. OTC Bulletin Board

Aktien

US68403P1049

Andere Sprachen

Filter